239 related articles for article (PubMed ID: 23047023)
1. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
2. Cholinesterase inhibitors and memory.
Pepeu G; Giovannini MG
Chem Biol Interact; 2010 Sep; 187(1-3):403-8. PubMed ID: 19941841
[TBL] [Abstract][Full Text] [Related]
3. Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients.
Bracco L; Bessi V; Padiglioni S; Marini S; Pepeu G
J Alzheimers Dis; 2014; 40(3):737-42. PubMed ID: 24577458
[TBL] [Abstract][Full Text] [Related]
4. [Tacrine].
Dávila C; Viteri C; de Castro P
Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
[TBL] [Abstract][Full Text] [Related]
5. A review on cholinesterase inhibitors for Alzheimer's disease.
Anand P; Singh B
Arch Pharm Res; 2013 Apr; 36(4):375-99. PubMed ID: 23435942
[TBL] [Abstract][Full Text] [Related]
6. Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
Jones RW
Int J Geriatr Psychiatry; 2003 Sep; 18(Suppl 1):S7-S13. PubMed ID: 12973745
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Crowell TA; Paramadevan J; Abdullah L; Mullan M
J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
[TBL] [Abstract][Full Text] [Related]
8. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer disease, attention, and the cholinergic system.
Lawrence AD; Sahakian BJ
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():43-9. PubMed ID: 8534423
[TBL] [Abstract][Full Text] [Related]
10. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
Haywood WM; Mukaetova-Ladinska EB
Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic therapies for Alzheimer's disease. Palliative or disease altering?
Davis RE; Doyle PD; Carroll RT; Emmerling MR; Jaen J
Arzneimittelforschung; 1995 Mar; 45(3A):425-31. PubMed ID: 7763338
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study.
Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G
Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427
[TBL] [Abstract][Full Text] [Related]
13. Detecting effects of donepezil on visual selective attention using signal detection parameters in Alzheimer's disease.
Foldi NS; White RE; Schaefer LA
Int J Geriatr Psychiatry; 2005 May; 20(5):485-8. PubMed ID: 15852461
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
Goekoop R; Scheltens P; Barkhof F; Rombouts SA
Brain; 2006 Jan; 129(Pt 1):141-57. PubMed ID: 16251213
[TBL] [Abstract][Full Text] [Related]
15. Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
Wynn ZJ; Cummings JL
Dement Geriatr Cogn Disord; 2004; 17(1-2):100-8. PubMed ID: 14564129
[TBL] [Abstract][Full Text] [Related]
16. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease.
Droogsma E; van Asselt D; Diekhuis M; Veeger N; van der Hooft C; De Deyn PP
Int Psychogeriatr; 2015 Aug; 27(8):1323-33. PubMed ID: 25779465
[TBL] [Abstract][Full Text] [Related]
17. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
[TBL] [Abstract][Full Text] [Related]
19. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
Vellas B; Cunha L; Gertz HJ; De Deyn PP; Wesnes K; Hammond G; Schwalen S;
Curr Med Res Opin; 2005 Sep; 21(9):1423-9. PubMed ID: 16197661
[TBL] [Abstract][Full Text] [Related]
20. [Alzheimer drugs for mild cognitive impairment].
Fellgiebel A
Neuropsychiatr; 2007; 21(3):230-3. PubMed ID: 17915184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
